A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Objective: To assess the efficacy of interferon beta (IFNß) in combination with methotrexate in treatment of patients with rheumatoid arthritis. Methods: 209 patients with active rheumatoid arthritis, who had been on methotrexate for at least six months and at a stable dose for four weeks before stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: van Holten, J, Pavelka, K, Vencovsky, J, Stahl, H, Rozman, B, Genovese, M, Kivitz, A, Alvaro, J, Nuki, G, Furst, D, Herrero-Beaumont, G, McInnes, I, Musikic, P, Tak, P
Formato: Artigo
Lenguaje:Inglês
Publicado: 2005
Materias:
Extended Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1755211/
https://ncbi.nlm.nih.gov/pubmed/15242865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2003.020347
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares